May 04, 2020
University of Oxford and Sound Pharmaceuticals complete Phase 2 Bipolar Disorder Study with SPI-1005
Feb 10, 2020
NeuroRx: Phase 3 Drug for Suicidal Bipolar Depression to Present at BIO CEO Conference
Jan 13, 2020
Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019
Oct 20, 2019
Juvenile Bipolar Research Foundation Hires Executive Director
Oct 10, 2019
PhRMA Report Shows Nearly 140 Medicines in Development to Treat Mental Illness
Sep 03, 2019
US Bipolar Disorder Market and Competitive Landscape 2019-2024: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape
Aug 28, 2019
Discovery Mood and Anxiety Program Opens Treatment Program For Youth In Orlando
Jun 03, 2019
NeuroRX to Present Phase 2 Efficacy Data for NRX-101 at 2019 BIO International Convention
May 30, 2019
NeuroRx Reports Phase 2 Efficacy for NRX-101, a Breakthrough Therapy Targeting Suicidal Bipolar Depression
May 28, 2019
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression
May 18, 2019
New Real-World Evidence Highlights Need for Interventions to Improve Outcomes for Patients Who Have Been Diagnosed with Major Depressive Disorder (MDD) and Suicide Ideation or Attempt
Apr 28, 2019
Author Jalesa Morrison Announces New Book: Four Years of Despair
Mar 12, 2019
Learning from Patients Yields Better Education on Depression
Mar 05, 2019
The Juvenile Bipolar Research Foundation Announces the Publication of an Article in the Journal of Psychiatry and Brain Science
Jan 31, 2019
Top 12 Advances in Psychiatric Research in 2018 from the Brain & Behavior Research Foundation
Jan 16, 2019
New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders
Jan 06, 2019
Impel Neuropharma Announces Positive Phase 1 Trial For INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Dec 20, 2018
JPLaw Arrives in Time for Christmas - General Practice Law Firm in Wilmington, Delaware to Begin Serving Clients Across the Tri-State Area
Dec 20, 2018
The London Psychiatry Centre: Life-changing Discovery for Bipolar Disorder Sufferers
Nov 27, 2018
What It Means to be Bipolar; Understanding symptoms and treatments